GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)
Clinical trial NCT05303701 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05303701
- Sponsor
- Samsung Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-07-01
- Primary completion
- 2028-01-01
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.